Lifecome Biochemistry Co.,Ltd. (SHE:002868)
China · Delayed Price · Currency is CNY 37.75
-0.32 (-0.84%)
At close: Mar 30, 2026
Lifecome Biochemistry Revenue
In the year 2025, Lifecome Biochemistry had annual revenue of 516.58M CNY, down -20.45%. Lifecome Biochemistry had revenue of 106.91M in the quarter ending December 31, 2025, a decrease of -39.73%.
Revenue
516.58M
Revenue Growth
-20.45%
P/S Ratio
11.36
Revenue / Employee
940.95K
Employees
549
Market Cap
5.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 516.58M | -132.79M | -20.45% |
| Dec 31, 2024 | 649.37M | 142.37M | 28.08% |
| Dec 31, 2023 | 507.00M | 177.15M | 53.71% |
| Jan 1, 2023 | 329.85M | -33.54M | -9.23% |
| Dec 31, 2021 | 363.39M | 55.24M | 17.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novogene | 2.17B |
| Kexing Biopharm | 1.54B |
| Xiangxue Pharmaceutical | 1.47B |
| Shenzhen Weiguang Biological Products | 1.14B |
| Wuhan Keqian Biology Co.,Ltd | 950.29M |
| Beijing Konruns Pharmaceutical | 871.31M |
| R&G PharmaStudies | 851.01M |
| GemPharmatech | 793.25M |